Anika Therapeutics (ANIK) Posts Quarterly Earnings Results, Beats Estimates By $0.19 EPS
Anika Therapeutics (NASDAQ:ANIK) released its earnings data on Thursday. The company reported $0.33 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.14 by $0.19, American Banking & Market News reports. The company had revenue of $17.80 million for the quarter, compared to the consensus estimate of $16.96 million.
Anika Therapeutics (NASDAQ:ANIK) opened at 26.67 on Thursday. Anika Therapeutics has a 52-week low of $9.13 and a 52-week high of $27.80. The stock’s 50-day moving average is $25.37 and its 200-day moving average is $19.95. The company has a market cap of $360.5 million and a price-to-earnings ratio of 26.68.
On a related note, analysts at Summer Street raised their price target on shares of Anika Therapeutics from $20.00 to $28.00 in a research note to investors on Friday, August 2nd. They now have a “buy” rating on the stock.
Anika Therapeutics, Inc (NASDAQ:ANIK) develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.